Immunome IMNM Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Immunome’s reported figures.
Based on trailing twelve months.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's operating margin?
- Immunome (IMNM) reported operating margin of -5,947.9% in Q1 2026.
- How has Immunome's operating margin changed year-over-year?
- Immunome's operating margin decreased by 198.2% year-over-year, from -1,994.3% to -5,947.9%.
- What is the long-term trend for Immunome's operating margin?
- Over 2 years (2023 to 2025), Immunome's operating margin has grown at a 103.3% compound annual growth rate (CAGR), from -781.4% to -3,228.8%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.